AI news impact · US stocks

Charles River Laboratories International, Inc. (CRL) news impact

On 2026-11-02 Wave Radar's AI rated the news on Charles River Laboratories International, Inc. as neutral (impact score +5%).

Charles River heads into Q3 earnings with mixed expectations, balancing segment revenue declines against gradual biopharma demand recovery.

Direction
Neutral
Impact score
+5%
Confidence
65%
Headlines read
5
Date
2026-11-02
Open CRL news in Wave Radar

AI assessment

Ahead of the official earnings report, investors remain in wait-and-see mode, balancing early biopharma recovery against preclinical softness.

Sector impact

Reflects a cautious stance across the broader contract research organization (CRO) and life sciences preclinical sector.

Headlines the AI read

Rating history

One rating per trading day the stock was covered.

More on Charles River Laboratories International, Inc.

CRL valuation · CRL gamma exposure

How the rating works

After each close Wave Radar collects the day's headlines and filings for a stock and asks an AI model what they mean for it. The rating is one of five levels from major negative to major positive; the impact score runs from −100% to +100%, and a rating built on a single uncorroborated source is capped. It describes the news, not the price outlook.

Figures are generated automatically from Wave Radar's published market data and refresh after each market close.